𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Risk of nonocular cancer in first-degree relatives of retinoblastoma patients

✍ Scribed by Jørgen H. Olsen; Jens Winther; Peter de Nully Brown


Publisher
Springer
Year
1990
Tongue
English
Weight
446 KB
Volume
85
Category
Article
ISSN
0340-6717

No coin nor oath required. For personal study only.

✦ Synopsis


The increased risk of nonocular cancer seen consistently in studies of survivors of retinoblastoma may be caused in part by the presence of a retinoblastoma gene that also predisposes to other cancers. It has been claimed that this gene also increases the risk for cancer among unaffected relatives of genetic retinoblastoma probands. We report here a population-based study of the risk of nonocular cancer in parents and siblings of persons notified to the Danish Cancer Registry with retinoblastoma during 1943-84. No excess was observed among first degree relatives of 61 genetic retinoblastoma probands, whereas a slight (10%) excess was seen among the parents of 115 nongenetic probands. The latter was the result of significant excesses of malignant melanoma (4 observed, 0.4 expected), multiple myeloma (2 observed, 0.2 expected) and osteogenic sarcoma (1 observed, 0.03 expected). The observed risk pattern cannot be explained by the presence of the retinoblastoma gene.


📜 SIMILAR VOLUMES


Cancer in first-degree relatives and ris
✍ Rikke Baastrup Nordsborg; Jaymie R. Meliker; Jan Wohlfahrt; Mads Melbye; Ole Raa 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 French ⚖ 138 KB 👁 1 views

## Abstract Familial aggregation of testicular cancer has been reported consistently, but it is less clear if there is any association between risk of testicular cancer and other cancers in the family. We conducted a population‐based case–control study to examine the relationship between risk of te

Cancer risk among patients with cystic f
✍ Marie Johannesson; Johan Askling; Scott M. Montgomery; Anders Ekbom; Shahram Bah 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 French ⚖ 67 KB 👁 1 views

## Abstract Patients with cystic fibrosis (CF) are at increased risk of some cancers. Little is known about the cancer risks among carriers heterozygous for the CF mutation and it is hypothesized this may be associated with reduced cancer risk. Using Swedish general population‐based registers, we i